| RS2545492865 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545492904 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545492910 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545493995 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545494283 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545501546 |
TMEM165
|
Health Risk |
Pathogenic |
TMEM165-congenital disorder of glycosylation, TMEM165-congenital disorder of glycosylation |
| RS2545508940 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545516405 |
SETD2
|
Health Risk |
Pathogenic |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS2545516986 |
SETD2
|
Health Risk |
Pathogenic |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS2545518838 |
TLK2
|
Health Risk |
Likely pathogenic |
— |
| RS2545519137 |
SETD2
|
Health Risk |
Likely pathogenic |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS2545536411 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2545542261 |
FOXP1
|
Health Risk |
Pathogenic |
— |
| RS2545542981 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2545543007 |
FOXP1
|
Health Risk |
Likely pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2545543509 |
FOXP1
|
Health Risk |
Pathogenic |
FOXP1-related disorder, FOXP1-related disorder |
| RS2545548503 |
CFI
|
Health Risk |
Pathogenic |
— |
| RS2545554447 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545554653 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545554704 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS2545574096 |
TRIM37
|
Health Risk |
Likely pathogenic |
— |
| RS2545574847 |
CACNA1G
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia 42, early-onset |
| RS2545574866 |
CACNA1G
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 42, Spinocerebellar ataxia type 42 |
| RS2545576663 |
LRIT3
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS2545584268 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545584373 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545594181 |
TOP3A
|
Health Risk |
Pathogenic |
— |
| RS2545600554 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS2545606322 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS2545606715 |
TOP3A
|
Health Risk |
Pathogenic |
— |
| RS2545606953 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2545607420 |
SETD2
|
Health Risk |
Likely pathogenic |
— |
| RS2545609940 |
TOP3A
|
Health Risk |
Pathogenic |
— |
| RS2545618993 |
TOP3A
|
Health Risk |
Pathogenic |
— |
| RS2545622367 |
TOP3A
|
Health Risk |
Likely pathogenic |
— |
| RS2545625859 |
TOP3A
|
Health Risk |
Likely pathogenic |
— |
| RS2545626859 |
SETD2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2545627174 |
GEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2545631303 |
SETD2
|
Health Risk |
Pathogenic |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS2545633212 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2545634062 |
TLK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 57 |
| RS2545634068 |
ROBO1
|
Health Risk |
Pathogenic |
— |
| RS2545634597 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2545635749 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS2545639161 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545640830 |
SETD2
|
Health Risk |
Likely pathogenic |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS2545642461 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545644526 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545645314 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545648723 |
SETD2
|
Health Risk |
Likely pathogenic |
SETD2-related disorder, SETD2-related disorder |
| RS2545651806 |
KLHL24
|
Health Risk |
Pathogenic |
Cardiomyopathy, familial hypertrophic |
| RS2545653924 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545660610 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2545660709 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545661006 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545662505 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Luscan-Lumish syndrome, Intellectual developmental disorder |
| RS2545663203 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2545663250 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2545663742 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545668182 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545668446 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545668456 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Distal myopathy with anterior tibial onset, Miyoshi muscular dystrophy 1 |
| RS2545668712 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545668961 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545669126 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545671972 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545673204 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545673510 |
DYSF
|
Health Risk |
Pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545673631 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545673738 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545673744 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545673821 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS2545674533 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545674586 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545674741 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545674772 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545674815 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545675638 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545675665 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545675679 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545675698 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545675846 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545676119 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545676752 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545677022 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545677218 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545677389 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545677398 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545677417 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545682324 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545682548 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545682776 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545683255 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545684869 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545684982 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545685014 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS2545685225 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545685563 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545686042 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS2545686090 |
MPL
|
Health Risk |
Likely pathogenic |
— |